[Our results with radical retropubic prostatectomy in the first hundred patients].
BACKGROUND
The most used treatment of localised prostate cancer is: retropubic radical prostatectomy.


OBJECTIVE
The authors present their own results, on the basis of detailed discussions of 100 cases and compare them with international ones.


METHODS
The authors analyse the data of 100 radically operated patients suffering of localised prostate cancer. The indication of the operations was based on the results of rectal digital examinations, serum PSA concentration levels and ultrasound guided, rectally performed, prostate biopsies. The average preoperative PSA level was 13.6 ng/ml; the mean age of the patients was 61.1 years. They analyse the early and late complications. They follow up the patients on a regular basis assessing the PSA level, continence and potency.


RESULTS
The operation time, blood loss, amount of blood transfusion all decreased linearly during operations performed between 1998 and 2005. The longest period of follow up lasted for 70 months; the shortest lasted for 5 months. None of the patients died in the course of an operation or in 30 days following it; they lost one patient 18 months after the operation because of progression. From the late complications: in 22% of all cases they noticed anastomotic stricture constrictions which were resolved by urethrotomy. From all patients: 86% are fully continent; the rest mostly have grade 1 incontinence (requiring 1 pad per day). Altogether 18% of all patients have retained their potency without the use of drugs or appliances.


CONCLUSIONS
The results are comparable to international data and are in harmony with them. Therefore early recognition and radical surgery of prostate tumors would be advisable.
Romics
Imre
I
Semmelweis Egyetem, Altalános Orvostudományi Kar, Urológiai Klinika, Budapest.
Pánovics
József
J
Majoros
Attila
A
Riesz
Péter
P
D000368:Aged; D003251:Constriction, Pathologic / Q000209:etiology / Q000601:surgery; D005500:Follow-Up Studies; D006801:Humans; D006814:Hungary; D008297:Male; D008875:Middle Aged; D017430:Prostate-Specific Antigen / Q000097:blood; D011468:Prostatectomy / Q000009:adverse effects / Q000379:methods*; D011471:Prostatic Neoplasms / Q000175:diagnosis / Q000276:immunology / Q000601:surgery*; D012189:Retrospective Studies; D014521:Urethra / Q000473:pathology
D017430:Prostate-Specific Antigen